2020-11306. Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments  

Document Information

Published:
05/27/2020
Department:
Health and Human Services Department
Agency:
Food and Drug Administration
EntryType:
Notice
Action:
Notice of public meeting; request for comments.
Document Number:
2020-11306
Dates:
The public meeting will take place remotely on June 22, 2020, from 9 a.m. to 11 a.m. See the SUPPLEMENTARY INFORMATION section for registration date and information.
Pages:
31783-31785 (3 pages)
Docket Numbers:
Docket No. FDA-2019-N-1875
SectionNoes:
PDF File:
2020-11306.pdf